Under 40 with no signs of hormonal dysfunction
Additionally, GLP-1 suppresses glucagon, another hormone responsible for raising blood sugar, further stabilizing glucose levels
ORahilly S, Turner RC
Prescribing GLP-1 drugs specifically for NASH represents off-label use
Researchers from the University of Oxford, supported by National Institute for Health and Care Research (NIHR) Oxford Health Biomedical Research Centre, have conducted a comprehensive overview of the potential benefits or harms of glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (better known as Ozempic/Wegovy) in various mental health conditions
Back in 1965, Samols and his colleagues had helpfully demonstrated that the L-cells reacted with antibodies specific to glucagon which activated the release of insulin (Samols, Marri, Marks, 1965)